National Academies Press: OpenBook

Priorities for the National Vaccine Plan (2010)

Chapter: Appendix E: History of Public Engagement at the National Vaccine Program Office

« Previous: Appendix D: Initial Guidance for an Update of the National Vaccine Plan: A Letter Report to the National Vaccine Program Office
Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×

Appendix E
History of Public Engagement at the National Vaccine Program Office

The committee has followed with great interest and appreciation the efforts of the National Vaccine Program Office (NVPO) and its National Vaccine Advisory Committee (NVAC) to engage the general public on the National Vaccine Plan and on the research agenda of the Immunization Safety Office (ISO). The activities conducted in 2008 and 2009 followed an occasional series of notable public engagement activities on vaccine policy issues spearheaded by the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), and NVPO over the past decade and a half.

In 2002, working through NVPO, the U.S. Public Health Service agencies and the Johnson Foundation in Wisconsin jointly sponsored the Wingspread Public Engagement Planning Group, which was facilitated by the Keystone Group (Keystone Center, 2003). The purpose of this group was to explore whether and how to enhance public engagement in government decision making on vaccine policy issues. The Wingspread Public Engagement Planning Group considered the recommendations of its Steering Committee and finalized its best judgment on how to enhance public engagement, which is captured in the proposal to create the Vaccine Policy Analysis Collaborative (VPACE), a 3-year demonstration project designed to conduct dialogue and collaborative deliberations on selected vaccine issues with representative segments of the general public and stakeholder groups (Hamlin, 2004).

In 2004, CDC convened a Blue Ribbon Panel of health and safety science professionals, as well as consumer advocates, to provide their independent assessments of CDC immunization safety activities, including the organizational placement of ISO (CDC, 2005).

Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×

Also in 2004, the NVAC’s Working Group on Public Participation convened a meeting to consider options for enhancing public participation in vaccine policy deliberations and to evaluate the proposal from the Wingspread Public Engagement Planning Group for VPACE.

In July 2005, the Public Engagement Pilot Project on Pandemic Influenza (PEPPPI) process was initiated to discuss and rank goals for a pandemic influenza vaccination program and to pilot-test a new model for engaging citizens on vaccine-related policy decisions. PEPPPI was sponsored by a network of 14 public and private organizations throughout the United States. The project provided “proof of principle” that a large and diverse group of citizens and stakeholders could be recruited successfully to deliberate thoughtfully, interact respectfully, and reach a productive agreement on the topic of immunizations (Bernier, 2006). The principal conclusions reached in the pilot project received serious consideration at the national level and were reflected in the national Pandemic Influenza Plan released in November 2005 (Bernier and Marcuse, 2005).

More recently, beginning in April 2008, NVAC (supported by NVPO) has been involved in two major public engagement activities: (1) a review of the draft ISO research agenda to identify gaps and help set priorities and (2) engagement with the public and other stakeholders to obtain input on the draft National Vaccine Plan. As part of the NVAC-NVPO process for the ISO agenda, one stakeholder and three public engagement workshops (convened in Alabama, Oregon, and Indiana) have been held; stakeholder and public comments have been solicited via the Federal Register and other outreach; and an NVAC vaccine safety writing group developed a list of research gaps and criteria for prioritizing items in the ISO research agenda, which was used as a basis for discussion at a stakeholder meeting in March 2009 (HHS, 2009b). The public engagement activities were coordinated by the Keystone Center, and the committee was greatly impressed by the systematic process that NVPO-NVAC and Keystone used.

For the draft National Vaccine Plan, NVPO has solicited feedback via the Federal Register; through vaccine-related meetings in which NVPO staff discussed the plan; and at an NVAC meeting in February 2009 to discuss the plan and comments on the draft plan received by NVPO. NVPO also held three public engagement activities in March and April 2009 in Saint Louis, Missouri; Syracuse, New York; and Columbus, Ohio (HHS, 2009a).

NVAC, with the support of NVPO, is also beginning work on a review of the current federal vaccine safety system and development of “a White Paper describing the infrastructure needs for a federal vaccine safety system to fully characterize the safety profile of vaccines in a timely manner, reduce adverse events whenever possible, and maintain and improve public confidence in vaccine safety” (HHS, 2009b). The committee praises CDC and ISO for going substantially beyond the recommendation of the 2005

Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×

Institute of Medicine committee that public input be obtained on the Vaccine Safety Datalink (VSD) research plan. CDC and ISO have opened the entire ISO agenda to public viewing and wide input, facilitated by NVAC and NVPO.

REFERENCES

Bernier, R.H. 2006 (March). Public Engagement Pilot Project on Pandemic Influenza (PEPPPI). Available: http://cdc.confex.com/recording/cdc/nic2006/pps/free/4db77adf5df9fff0d3caf5cafe28f496/paper11639_2.pps [accessed January 27, 2009].

Bernier, R.H., and E.K. Marcuse. 2005. Citizen Voices on Pandemic Flu Choices: A Report of the Public Engagement Pillot Project on Pandemic Influenza. Available: http://ppc.nebraska.edu/documents/PEPPPI_FINALREPORT_DEC_2005.pdf [accessed January 27, 2009].

CDC (Centers for Disease Control and Prevention). 2005. Blue Ribbon Panel Meeting, Summary Report, June 3 and 4, 2004. Available: http://www.cdc.gov/od/ads/brpr/brprsumm.htm [accessed January 27, 2009].

Hamlin, M.D. 2004. Vaccine Policy Analysis Collaborative. Available: http://www.hhs.gov/nvpo/meetings/sep2004/VPACE.ppt#263 [accessed January 27, 2009].

HHS (Department of Health and Human Services). 2009a. U.S. National Vaccine Plan. Available: http://www.hhs.gov/nvpo/vacc_plan/index.html [accessed August 13, 2009].

HHS. 2009b. Vaccine Safety Working Group. Available: http://www.hhs.gov/nvpo/nvac/subgroups/vaccinesafety.html#1 [accessed August 13, 2009].

Keystone Center. 2003. Final Summary Report and Proposal for the Vaccine Policy Analysis Collaborative (VPACE). Available: http://keystone.org/files/file/about/publications/VPACE_FINALREPORT10_04.pdf [accessed January 27, 2009].

Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×

This page intentionally left blank.

Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×
Page 313
Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×
Page 314
Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×
Page 315
Suggested Citation:"Appendix E: History of Public Engagement at the National Vaccine Program Office." Institute of Medicine. 2010. Priorities for the National Vaccine Plan. Washington, DC: The National Academies Press. doi: 10.17226/12796.
×
Page 316
Next: Appendix F: Agendas of Stakeholder Meetings Held by the Committee on Review of Priorities in the National Vaccine Plan (July 2008-June 2009) »
Priorities for the National Vaccine Plan Get This Book
×
Buy Paperback | $67.00 Buy Ebook | $54.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Vaccination is a fundamental component of preventive medicine and public health. The use of vaccines to prevent infectious diseases has resulted in dramatic decreases in disease, disability, and death in the United States and around the world. The current political, economic, and social environment presents both opportunities for and challenges to strengthening the U.S. system for developing, manufacturing, regulating, distributing, funding, and administering safe and effective vaccines for all people. Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services.

Priorities for the National Vaccine Plan examines the extraordinarily complex vaccine enterprise, from research and development of new vaccines to financing and reimbursement of immunization services. The book makes recommendations about priority actions in the update to the National Vaccine Plan that are intended to achieve the objectives of disease prevention and enhancement of vaccine safety. It is centered on the plan's five goals in the areas of vaccine development, safety, communication, supply and use, and global health.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!